HR Monthly Round Up - December 2025
Welcome, everyone! In the next few minutes, we’ll review the latest HR news. Let’s get started.
Artificial intelligence, revenue growth, and attracting top talent are on business leaders’ minds for 2026, according to the CEO Priorities and Perspectives study released December 4 by the Society for Human Resource Management. The study, which was conducted in October 2025, was based on a survey of 116 CEOs.
While 87 percent of CEOs surveyed see AI-driven upskilling and reskilling to be prevalent in 2026, the cost of labor is a concern. The survey indicated that 81 percent of CEOs expect rising labor and total workforce costs, and 75 percent anticipate workforce reductions to be a trend in the new year.
In other news, on December 3, two senators introduced bipartisan legislation called the Fair Access for Individuals to Receive Leave Act. If enacted, the bill would eliminate the requirement that married couples who both work for the same employer share the 12 weeks of leave under the federal Family and Medical Leave Act in certain circumstances, such as when the leave is taken to bond with a healthy newborn child.
If this bill gets enacted, employers would have an easier time tracking FMLA leave and employees would have more leave flexibility. Although this bill might not pass, it indicates that revising legislation about employee leave is still on the minds of lawmakers.
One more quick update, the White House has directed the attorney general to speed up the process of reclassifying marijuana as a less dangerous drug. An executive order signed December 18 brings new life to a process that began in 2024 when the federal government published a proposed rule that would move marijuana from schedule I of the Controlled Substances Act to schedule III, a lower-class drug category.
The rescheduling proposal would move marijuana to the same drug class as prescription drugs such as Tylenol with codeine, ketamine, and steroids. It would also make it possible for medical marijuana to be prescribed to patients.
While the executive order revives the marijuana rescheduling issue, it will likely be 6-12 months before a final rule is issued. Hearings will need to be scheduled and comments from the hearings will need to be considered before a final rule is published.
That’s all the HR news we have time for today. Thanks for watching. See you next month!

















































